Skip to main content

Table 2 Treatment methods for the enrolled patients

From: Whole brain radiation therapy does not improve the overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastasis

 

WBRT (n = 26)

non-WBRT (n = 25)

WBRT alone

3

0

EGFR-TKIs alone

0

9

ChT alone

0

9

WBRT+EGFR-TKIs

20

0

WBRT+ChT

3

0

EGFR-TKIs+ChT

0

7

  1. EGFR Epidermal growth factor receptor, TKI Tyrosine kinase inhibitor, ChT Chemotherapy, WBRT Whole brain radiotherapy
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us